147 related articles for article (PubMed ID: 16344721)
1. Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta.
Siezen CL; Tijhuis MJ; Kram NR; van Soest EM; de Jong DJ; Fodde R; van Kranen HJ; Kampman E
Pharmacogenet Genomics; 2006 Jan; 16(1):43-50. PubMed ID: 16344721
[TBL] [Abstract][Full Text] [Related]
2. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.
Siezen CL; van Leeuwen AI; Kram NR; Luken ME; van Kranen HJ; Kampman E
Carcinogenesis; 2005 Feb; 26(2):449-57. PubMed ID: 15550453
[TBL] [Abstract][Full Text] [Related]
3. No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma.
McGreavey LE; Turner F; Smith G; Boylan K; Timothy Bishop D; Forman D; Roland Wolf C; Barrett JH;
Pharmacogenet Genomics; 2005 Oct; 15(10):713-21. PubMed ID: 16141797
[TBL] [Abstract][Full Text] [Related]
4. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
Nan H; Hutter CM; Lin Y; Jacobs EJ; Ulrich CM; White E; Baron JA; Berndt SI; Brenner H; Butterbach K; Caan BJ; Campbell PT; Carlson CS; Casey G; Chang-Claude J; Chanock SJ; Cotterchio M; Duggan D; Figueiredo JC; Fuchs CS; Giovannucci EL; Gong J; Haile RW; Harrison TA; Hayes RB; Hoffmeister M; Hopper JL; Hudson TJ; Jenkins MA; Jiao S; Lindor NM; Lemire M; Le Marchand L; Newcomb PA; Ogino S; Pflugeisen BM; Potter JD; Qu C; Rosse SA; Rudolph A; Schoen RE; Schumacher FR; Seminara D; Slattery ML; Thibodeau SN; Thomas F; Thornquist M; Warnick GS; Zanke BW; Gauderman WJ; Peters U; Hsu L; Chan AT; ;
JAMA; 2015 Mar; 313(11):1133-42. PubMed ID: 25781442
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.
Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM
Pharmacogenet Genomics; 2009 Feb; 19(2):113-20. PubMed ID: 19077918
[TBL] [Abstract][Full Text] [Related]
6. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
8. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway.
Slattery ML; Samowitz W; Hoffman M; Ma KN; Levin TR; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):538-45. PubMed ID: 15066917
[TBL] [Abstract][Full Text] [Related]
9. Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.
Ali IU; Luke BT; Dean M; Greenwald P
Br J Cancer; 2005 Oct; 93(8):953-9. PubMed ID: 16205694
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
11. Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.
Daugherty SE; Platz EA; Shugart YY; Fallin MD; Isaacs WB; Chatterjee N; Welch R; Huang WY; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1536-42. PubMed ID: 17684125
[TBL] [Abstract][Full Text] [Related]
12. Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.
Barry EL; Mott LA; Sandler RS; Ahnen DJ; Baron JA
Cancer Prev Res (Phila); 2011 Dec; 4(12):2072-82. PubMed ID: 21930798
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
[TBL] [Abstract][Full Text] [Related]
14. Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use.
Chia VM; Newcomb PA; Bigler J; Morimoto LM; Thibodeau SN; Potter JD
Cancer Res; 2006 Jul; 66(13):6877-83. PubMed ID: 16818666
[TBL] [Abstract][Full Text] [Related]
15. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
[TBL] [Abstract][Full Text] [Related]
16. Does nonsteroidal anti-inflammatory drug use modify the effect of a low-fat, high-fiber diet on recurrence of colorectal adenomas?
Hartman TJ; Yu B; Albert PS; Slattery ML; Paskett E; Kikendall JW; Iber F; Brewer BK; Schatzkin A; Lanza E
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2359-65. PubMed ID: 16214917
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon.
Liou JY; Ghelani D; Yeh S; Wu KK
Cancer Res; 2007 Apr; 67(7):3185-91. PubMed ID: 17409426
[TBL] [Abstract][Full Text] [Related]
18. Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma.
Hoeft B; Becker N; Deeg E; Beckmann L; Nieters A
Cancer Causes Control; 2008 Mar; 19(2):163-73. PubMed ID: 18038187
[TBL] [Abstract][Full Text] [Related]
19. Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study.
García Rodríguez LA; Huerta-Alvarez C
Epidemiology; 2000 Jul; 11(4):376-81. PubMed ID: 10874542
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.
Kleinstein SE; Heath L; Makar KW; Poole EM; Seufert BL; Slattery ML; Xiao L; Duggan DJ; Hsu L; Curtin K; Koepl L; Muehling J; Taverna D; Caan BJ; Carlson CS; Potter JD; Ulrich CM
Genes Chromosomes Cancer; 2013 May; 52(5):437-49. PubMed ID: 23404351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
